ProQR Therapeutics N.V. SEC filings PRQR
ProQR Therapeutics N.V. has 391 filings in SEC EDGAR's recent list, going back to Jul 11, 2014. Its latest annual report, Form 20-F, was filed on Mar 12, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 28, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Jul 15, 2026 | — |
| EFFECT | Filing | Mar 25, 2025 | — |
| CORRESP | Letter to the SEC | Mar 21, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 20, 2025 | — |
| EFFECT | Filing | Oct 10, 2024 | — |
| CORRESP | Letter to the SEC | Oct 8, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 7, 2024 | — |
| EFFECT | Filing | Apr 24, 2023 | — |
| CORRESP | Letter to the SEC | Apr 20, 2023 | — |
| UPLOAD | Letter from the SEC | Apr 4, 2023 | — |
| RW | Filing | Mar 29, 2023 | — |
| EFFECT | Filing | Mar 9, 2022 | — |
| CORRESP | Letter to the SEC | Mar 7, 2022 | — |
| UPLOAD | Letter from the SEC | Mar 4, 2022 | — |
| EFFECT | Filing | Nov 16, 2021 | — |
| CORRESP | Letter to the SEC | Nov 12, 2021 | — |
| UPLOAD | Letter from the SEC | Nov 10, 2021 | — |
| EFFECT | Filing | Sep 18, 2020 | — |
| CORRESP | Letter to the SEC | Sep 16, 2020 | — |
| UPLOAD | Letter from the SEC | Sep 15, 2020 | — |
| CT ORDER | Filing | Apr 23, 2019 | — |
| EFFECT | Filing | Nov 19, 2018 | — |
| CORRESP | Letter to the SEC | Nov 15, 2018 | — |
| UPLOAD | Letter from the SEC | Nov 14, 2018 | — |
| CT ORDER | Filing | Apr 9, 2018 | — |
| UPLOAD | Letter from the SEC | Oct 16, 2017 | — |
| CORRESP | Letter to the SEC | Oct 10, 2017 | — |
| UPLOAD | Letter from the SEC | Sep 29, 2017 | — |
| CT ORDER | Filing | Apr 13, 2017 | — |
| EFFECT | Filing | Oct 19, 2015 | — |
| CORRESP | Letter to the SEC | Oct 15, 2015 | — |
| UPLOAD | Letter from the SEC | Oct 14, 2015 | — |
| CT ORDER | Filing | Nov 13, 2014 | — |
| CT ORDER | Filing | Sep 22, 2014 | — |
| CERTNAS | Auto-generated paper document | Sep 17, 2014 | — |
| EFFECT | Filing | Sep 17, 2014 | — |
| CORRESP | Letter to the SEC | Sep 16, 2014 | — |
| CORRESP | Letter to the SEC | Sep 16, 2014 | — |
| 8-A12B | Form 8-a12b | Sep 16, 2014 | — |
| UPLOAD | Letter from the SEC | Aug 29, 2014 | — |
| CORRESP | Letter to the SEC | Aug 27, 2014 | — |
| CORRESP | Letter to the SEC | Aug 14, 2014 | — |
| UPLOAD | Letter from the SEC | Aug 7, 2014 | — |
| DRS | Filing | Jul 11, 2014 | — |
Showing 44 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PRQR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Netherlands
- Headquarters
- Leiden
- SEC filer status
- Accelerated filer
- SEC CIK
- 1612940
- Former names
- ProQR Therapeutics B.V. (until Oct 3, 2014)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.